Literature DB >> 3427732

Diketopiperazine derivatives, a new series of platelet-activating factor inhibitors.

N Shimazaki, I Shima, K Hemmi, Y Tsurumi, M Hashimoto.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1987        PMID： 3427732     DOI： 10.1248/cpb.35.3527

Source DB:  PubMed          Journal:  Chem Pharm Bull (Tokyo)        ISSN： 0009-2363            Impact factor:   1.645


× No keyword cloud information.
  4 in total

1.  Synthesis and biological evaluation of epidithio-, epitetrathio-, and bis-(methylthio)diketopiperazines: synthetic methodology, enantioselective total synthesis of epicoccin G, 8,8'-epi-ent-rostratin B, gliotoxin, gliotoxin G, emethallicin E, and haematocin and discovery of new antiviral and antimalarial agents.

Authors:  K C Nicolaou; Min Lu; Sotirios Totokotsopoulos; Philipp Heretsch; Denis Giguère; Ya-Ping Sun; David Sarlah; Thu H Nguyen; Ian C Wolf; Donald F Smee; Craig W Day; Selina Bopp; Elizabeth A Winzeler
Journal:  J Am Chem Soc       Date:  2012-10-04       Impact factor: 15.419

Review 2.  A brief history of antibiotics and select advances in their synthesis.

Authors:  Kyriacos C Nicolaou; Stephan Rigol
Journal:  J Antibiot (Tokyo)       Date:  2017-07-05       Impact factor: 2.649

3.  Quantitative Modeling of Bis(pyridine)silver(I) Permanganate Oxidation of Hydantoin Derivatives: Guidelines for Predicting the Site of Oxidation in Complex Substrates.

Authors:  Amanda J Bischoff; Brandon M Nelson; Zachary L Niemeyer; Matthew S Sigman; Mohammad Movassaghi
Journal:  J Am Chem Soc       Date:  2017-10-18       Impact factor: 15.419

4.  PAF inhibitory activity of diketopiperazines: structure-activity relationships.

Authors:  N Shimazaki; I Shima; M Okamoto; K Yoshida; K Hemmi; M Hashimoto
Journal:  Lipids       Date:  1991-12       Impact factor: 1.880
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.